Tag: medical-devices
Boston Scientific Stock Analysis: Buy or Sell? Valuation & Growth Outlook
Boston Scientific (BSX) is rated Hold as strong organic growth and clinical momentum are offset by a valuation that already reflects much of the upside. The key question is whether BSX can keep growing fast enough to justify 13.4x EV/EBITDA while managing a $12.6B debt load.
Stryker Stock Analysis: Buy or Sell? Valuation, Margins & Risk
Stryker (SYK) is a HOLD as strong margins and free cash flow support the business, but the valuation already discounts much of that quality. Execution risk, including insider selling and a cyber incident, keeps the setup from looking cheap.
Stereotaxis Stock Analysis: Buy or Sell? Cash Burn, Revenue, Valuation & Margins
Stereotaxis (STXS) is rated Sell as uneven revenue and ongoing cash burn outweigh the platform’s gross-margin potential. A 4.6x EV/revenue multiple looks demanding while levered free cash flow remains negative, keeping dilution and execution risk front and center.
Novanta Stock Analysis: Buy or Sell? Valuation, FCF & Margins
Novanta (NOVT) is rated Hold as its net cash balance sheet and 8.7% free cash flow margin are offset by a 5.2x EV/revenue multiple and 36.1x forward P/E. Q1 2026 revenue rose 10.4%, but earnings still declined, leaving the stock priced for cleaner execution than the latest results support.
Intuitive Surgical Stock Analysis: Valuation, Procedure Growth, China Risk & Cash Flow
Intuitive Surgical (ISRG) earns a HOLD rating as its dominant installed base and recurring revenue continue to support strong cash generation. However, the stock already prices in durable execution at a rich valuation, with China tender delays and pricing pressure clouding near-term upside.